BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations

Loading... Wednesday, Elevance Health Inc. ELV reported second-quarter revenues of $43.2 billion, down 0.4% yearover-year, marginally above the consensus of $43.05 billion. BofA Securities observes that Elevance Health has traditionally been seen as an investment lacking Medicare Advantage (MA) exposure. However, this perception may change following UnitedHealth's stronger-thanexpected results and a potentially improving regulatory landscape. The analyst writes, "Ultimately, we believe rates will reflect ac ...